Symbol="HRMY"
AssetType="Common Stock"
Name="Harmony Biosciences Holdings"
Description="Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania."
CIK="1802665"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2119395000"
EBITDA="157303000"
PERatio="11.15"
PEGRatio="None"
BookValue="7.39"
DividendPerShare="0"
DividendYield="0"
EPS="3.17"
RevenuePerShareTTM="7.94"
ProfitMargin="0.402"
OperatingMarginTTM="0.282"
ReturnOnAssetsTTM="0.141"
ReturnOnEquityTTM="0.576"
RevenueTTM="471668000"
GrossProfitTTM="354374000"
DilutedEPSTTM="3.17"
QuarterlyEarningsGrowthYOY="0.371"
QuarterlyRevenueGrowthYOY="0.396"
AnalystTargetPrice="59.88"
TrailingPE="11.15"
ForwardPE="25.64"
PriceToSalesRatioTTM="8.31"
PriceToBookRatio="10.12"
EVToRevenue="8.39"
EVToEBITDA="27.25"
Beta="0.436"
num_52WeekHigh="62.09"
num_52WeekLow="29.81"
num_50DayMovingAverage="35.53"
num_200DayMovingAverage="44.55"
SharesOutstanding="59940000"
DividendDate="None"
ExDividendDate="None"
symbol="HRMY"
open="35.53"
high="36.75"
low="35.41"
price="36.44"
volume="436342.00"
latest_trading_day="2023-07-17"
previous_close="35.35"
change="1.09"
change_percent="3.0835%"
aroon_positive_momentum_days="16"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="748061"
Change_recent_avg="-0.08"
Delta_recent_avg="1.4"
Variance_recent_avg="0.7"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="1126"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0159.jpeg"
image_negative_thumbnail_id_2="1111"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0144.jpeg"
image_neutral_thumbnail_id_1="543"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="666"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0042.jpeg"
image_positive_thumbnail_id_2="641"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0067.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
